نتائج البحث - "Nardone A."

1

دورية أكاديمية

Inflammatory status affects the antitumor activity of poly-epitope-peptide vaccination against the thymidylate synthase in metastatic colo-rectal cancer patients enrolled in TSPP/VAC-1 Phase Ib trial

المؤلفون: Correale, Pierpaolo, Nardone, Valerio, Botta, Cirino, Martino, Elodia, Pastina, Pierpaolo, Ulivieri, Cristina, Rossetti, Maria, Fioravanti, Antonella, Gandolfo, Claudia, Carbone, Francesco, Baldari, Tatiana, Tagliaferri, Pierosandro, Pirtoli, Luigi, Cusi, Maria

المصدر: Journal for ImmunoTherapy of Cancer ; volume 3, issue Suppl 2, page P443 ; ISSN 2051-1426

مصطلحات موضوعية: Cancer Research, Pharmacology, Oncology, Molecular Medicine, Immunology, Immunology and Allergy

الإتاحة: https://doi.org/10.1186/2051-1426-3-s2-p443Test

View record in BASE

2

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse

المساهمون: Nardone, Valerio, Botta, Cirino, Caraglia, Michele, Martino, Elodia Claudia, Ambrosio, Maria Raffaella, Carfagno, Tommaso, Tini, Paolo, Semeraro, Leonardo, Misso, Gabriella, Grimaldi, Anna, Boccellino, Mariarosaria, Facchini, Gaetano, Berretta, Massimiliano, Vischi, Gianluca, Rocca, Bruno Jim, Barone, Aurora, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, del Vecchio, Maria Teresa, Pirtoli, Luigi, Correale, Pierpaolo, Nardone V., Botta C., Caraglia M., Martino E.C., Ambrosio M.R., Carfagno T., Tini P., Semeraro L., Misso G., Grimaldi A., Boccellino M., Facchini G., Berretta M., Vischi G., Rocca B.J., Barone A., Tassone P., Tagliaferri P., del Vecchio M.T., Pirtoli L., Correale P.

المصدر: Cancer Biology & Therapy. 17:1213-1220

مصطلحات موضوعية: Male, 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Chemokyne Receptor 7, Prostate cancer, 0302 clinical medicine, Recurrence, PD-1, Tumor Microenvironment, Forkhead Transcription Factors, hemic and immune systems, prostate cancer, Primary tumor, disease-free survival, FoxP3, overall survival, prognosis, radiotherapy, T regulators lymphocytes, tumor infiltrating lymphocytes, 030220 oncology & carcinogenesis, Molecular Medicine, prognosi, Research Paper, Receptors, CCR7, medicine.medical_specialty, chemical and pharmacologic phenomena, 03 medical and health sciences, Lymphocytes, Tumor-Infiltrating, Median follow-up, Internal medicine, Pharmacology, medicine, Humans, Progression-free survival, Radical surgery, Aged, Salvage Therapy, business.industry, Tumor-infiltrating lymphocytes, Prostatic Neoplasms, medicine.disease, Radiation therapy, T regulators lymphocyte, 030104 developmental biology, Tumor progression, tumor infiltrating lymphocyte, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b13e6241b6ab858dea12c198f1cd5dfaTest
https://doi.org/10.1080/15384047.2016.1235666Test

3

Costs of clinical trials with anticancer biological agents in an Oncologic Italian Cancer Center using the activity-based costing methodology

المساهمون: Pascarella, Giacomo, Capasso, Arturo, Nardone, Antonio, Triassi, Maria, Pignata, Sandro, Arenare, Laura, Ascierto, Paolo, Curvietto, Marcello, Maiolino, Piera, D'Aniello, Roberta, Montanino, Agnese, Laudato, Francesca, De Feo, Gianfranco, Botti, Gerardo, Perrone, Francesco, Petrillo, Antonella, Cavalcanti, Ernesta, Lastoria, Secondo, Maurea, Nicola, Morabito, Alessandro

المصدر: PLoS ONE, Vol 14, Iss 1, p e0210330 (2019)
PLoS ONE

مصطلحات موضوعية: Male, Melanomas, Total cost, Cancer Treatment, Antineoplastic Agents, Immunological, 0302 clinical medicine, Neoplasms, Health care, Medicine and Health Sciences, Multicenter Studies as Topic, Medicine, 030212 general & internal medicine, Clinical Trials (Cancer Treatment), Activity-based costing, health care economics and organizations, Randomized Controlled Trials as Topic, Multidisciplinary, Health Care Costs, Anticancer Biological, Phase III clinical investigation, Italy, Oncology, Female, Oncology Agents, Research Article, medicine.medical_specialty, Drug Research and Development, Science, Immunology, MEDLINE, Antineoplastic Agents, Audit, Research and Analysis Methods, Drug Costs, 03 medical and health sciences, Antibody Therapy, Diagnostic Medicine, Humans, Clinical Trials, Pharmacology, business.industry, Cancers and Neoplasms, Biology and Life Sciences, Cancer, medicine.disease, Clinical trial, Clinical Trials, Phase III as Topic, Family medicine, 030221 ophthalmology & optometry, Clinical Immunology, Clinical Medicine, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::36c668cea8590fc7a505541b0b4acbd0Test
https://doaj.org/article/56b60e557d7249d98acd2f419d2dfc17Test

4

دورية أكاديمية

Molecular expression of Gastrokine 1 in normal mucosa and in Helicobacter pylori-related preneoplastic and neoplastic gastric lesions.

المؤلفون: Emilia Rippa, F. Caruso, G. Martin, Gerardo Nardone, Alice Di Rocco, La Monica G, Paolo Arcari

مصطلحات موضوعية: Aurora Universities Network, Cancer Research, Pharmacology, Oncology, Molecular Medicine

العلاقة: url:https://www.openaccessrepository.it/communities/itmirrorTest; https://www.openaccessrepository.it/record/128697Test

الإتاحة: https://doi.org/10.4161/cbt.7.12.6936Test
https://www.openaccessrepository.it/record/128697Test

View record in BASE

5

Distinctive germline expression of class I human leukocyte antigen (HLA) alleles and DRB1 heterozygosis predict the outcome of patients with non-small cell lung cancer receiving PD-1/PD-L1 immune checkpoint blockade

المساهمون: Correale, P., Saladino, R. E., Giannarelli, D., Giannicola, R., Agostino, R., Staropoli, N., Strangio, A., Del Giudice, T., Nardone, V., Altomonte, M., Pastina, P., Tini, P., Falzea, A. C., Imbesi, N., Arcati, V., Romeo, G., Caracciolo, D., Luce, A., Caraglia, M., Giordano, A., Pirtoli, L., Necas, A., Amler, E., Barbieri, V., Tassone, P., Tagliaferri, P.

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Immunology, Human leukocyte antigen, Cancer immunotherapy, HLA Antigens, Carcinoma, Non-Small-Cell Lung, Immunotherapy Biomarkers, medicine, Humans, Immunology and Allergy, Cytotoxic T cell, Lung cancer, Immune Checkpoint Inhibitors, Alleles, Germ-Line Mutation, RC254-282, Aged, Retrospective Studies, Pharmacology, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, medicine.disease, Survival Analysis, lung neoplasm, Immune checkpoint, HLA-A, antigen presentation, Treatment Outcome, Oncology, tumor biomarkers, B7-H1 antigen, Cancer research, Molecular Medicine, Female, Nivolumab, business, B7-H1 Antigen

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a1905deaf39a4611f9d4981936aae8b4Test
https://doi.org/10.1136/jitc-2020-000733Test

6

Skin cancer associated with commonly prescribed drugs: tumor necrosis factor alpha inhibitors (TNF-αIs), angiotensin-receptor blockers (ARBs), phosphodiesterase type 5 inhibitors (PDE5Is) and statins -weighing the evidence

المؤلفون: Beatrice Nardone, Paras P. Vakharia, Dennis P. West, Kelsey A. Orrell

المصدر: Expert opinion on drug safety. 17(2)

مصطلحات موضوعية: Oncology, Drug, medicine.medical_specialty, Skin Neoplasms, media_common.quotation_subject, Pharmacology, 03 medical and health sciences, Angiotensin Receptor Antagonists, 0302 clinical medicine, Internal medicine, medicine, Humans, Pharmacology (medical), Basal cell carcinoma, 030212 general & internal medicine, Melanoma, media_common, integumentary system, biology, business.industry, Tumor Necrosis Factor-alpha, Incidence (epidemiology), Incidence, General Medicine, Phosphodiesterase 5 Inhibitors, medicine.disease, Carcinoma, Basal Cell, 030220 oncology & carcinogenesis, HMG-CoA reductase, biology.protein, Carcinoma, Squamous Cell, Tumor necrosis factor alpha, Skin cancer, Hydroxymethylglutaryl-CoA Reductase Inhibitors, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::afa239305ef2449d8697560a5d225c80Test
https://pubmed.ncbi.nlm.nih.gov/29103328Test

7

دورية أكاديمية

Tumor infiltrating T lymphocytes expressing FoxP3, CCR7 or PD-1 predict the outcome of prostate cancer patients subjected to salvage radiotherapy after biochemical relapse

المساهمون: Nardone, Valerio, Botta, Cirino, Caraglia, Michele, Martino, Elodia Claudia, Ambrosio, MARIA RAFFAELLA, Carfagno, Tommaso, Tini, Paolo, Semeraro, Leonardo, Misso, Gabriella, Grimaldi, Anna, Boccellino, Mariarosaria, Facchini, Gaetano, Berretta, Massimiliano, Vischi, Gianluca, Rocca, BRUNO JIM, Barone, Aurora, Tassone, Pierfrancesco, Tagliaferri, Pierosandro, DEL VECCHIO, MARIA TERESA, Pirtoli, Luigi, Correale, Pierpaolo

مصطلحات موضوعية: Chemokyne Receptor 7, disease-free survival, FoxP3, overall survival, PD-1, prognosi, prostate cancer, radiotherapy, T regulators lymphocyte, tumor infiltrating lymphocyte, Molecular Medicine, Oncology, Pharmacology, Cancer Research

وصف الملف: STAMPA

العلاقة: info:eu-repo/semantics/altIdentifier/pmid/27791459; info:eu-repo/semantics/altIdentifier/wos/WOS:000389702800011; volume:17; issue:11; firstpage:1213; lastpage:1220; numberofpages:8; journal:CANCER BIOLOGY & THERAPY; http://hdl.handle.net/11365/1007125Test; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-84997284759; http://www.tandfonline.com/loi/kcbt20Test

الإتاحة: https://doi.org/10.1080/15384047.2016.1235666Test
http://hdl.handle.net/11365/1007125Test
http://www.tandfonline.com/loi/kcbt20Test

View record in BASE